Skip to main content
. 2018 Mar 27;34(4):648–652. doi: 10.1007/s12288-018-0953-x

Table 2.

Change in bone mineral density after 12 months therapy with zoledronic acid

Site BMD change (g/cm2)
Median (range)
BMD change (%)
Median (range)
Lumbar 0.041 (− 0.073 to 0.162) 5.4% (− 7 to 27.8%)
Hip 0.016 (− 0.113 to 0.101) 2.2% (− 12.4 to 13.4%)
Forearm 0.010 (− 0.023 to 0.047) 1.8% (− 5.9 to 9.9%)
Overall 0.028 (− 0.113 to 0.162) 3.2% (− 12.4 to 27.8%)